object
casecontrol
studi
conduct
assess
season
influenza
vaccin
effect
sive
influenza
season
method
studi
perform
three
depart
lithuania
decemb
may
data
demograph
clinic
characterist
includ
influenza
vaccin
statu
collect
patient
recommend
receiv
season
influenza
vaccin
influenza
viru
infect
confirm
multiplex
revers
transcript
polymeras
chain
reaction
rtpcr
result
ninetyon
includ
subject
year
old
fifteen
subject
vaccin
influenza
least
week
onset
influenza
symptom
year
old
influenza
viru
posit
case
confirm
influenza
includ
case
influenza
eight
confirm
influenza
b
one
coinfect
unadjust
sive
influenza
influenza
type
influenza
ci
ci
ci
respect
conclus
although
sive
estim
statist
signific
point
estim
suggest
moder
effect
influenza
type
influenza
highli
contagi
viral
airborn
diseas
northern
hemispher
typic
occur
winter
month
annual
influenza
epidem
result
high
morbid
three
five
million
case
sever
ill
signific
mortal
rate
death
worldwid
addit
peopl
chronic
underli
medic
condit
year
old
older
influenza
associ
signific
advers
health
outcom
influenzarel
hospitalis
death
effect
way
prevent
potenti
sever
influenza
complic
vaccin
annual
influenza
immunis
recommend
vulner
group
adult
age
year
peopl
comorbid
howev
evid
base
recommend
weak
except
randomis
control
trial
base
result
observ
studi
lack
laboratori
confirm
influenza
infect
assess
influenza
vaccin
effect
nonspecif
outcom
major
limit
major
exist
observ
studi
rel
recent
testneg
casecontrol
studi
introduc
assess
season
influenza
vaccin
effect
sive
despit
limit
current
consid
accur
effici
way
monitor
sive
due
frequent
chang
circul
influenza
strain
sive
monitor
routin
basi
use
guid
influenza
prevent
inform
treatment
strategi
influenza
epidem
could
also
help
make
decis
next
season
influenza
vaccin
content
furthermor
due
differ
time
spread
influenza
virus
across
europ
sive
estim
deriv
differ
geograph
area
particular
interest
great
relev
well
lithuania
year
age
pregnant
women
peopl
underli
medic
condit
healthcar
worker
elig
receiv
influenza
vaccin
free
charg
vaccin
use
immunis
risk
group
lithuania
trival
influenza
vaccin
influenza
season
one
dose
subunit
influenza
vaccin
influvac
bgp
product
hoofddorp
netherland
use
accord
recommend
object
studi
measur
sive
laboratoryconfirm
influenza
patient
admit
hospit
due
sever
acut
respiratori
infect
sari
lithuania
testneg
casecontrol
studi
conduct
decemb
may
subject
recruit
three
particip
site
centr
infecti
diseas
vilniu
univers
hospit
santaro
kliniko
vilniu
lithuania
depart
infecti
diseas
depart
geriatr
lithuanian
univers
health
scienc
kauna
studi
popul
consist
year
older
individu
underli
medic
condit
healthi
year
old
individu
pregnant
women
live
commun
admit
one
particip
site
due
sari
contraind
influenza
vaccin
allergi
influenza
vaccin
advers
event
vaccin
past
patient
elig
includ
studi
hospitalis
least
hour
longer
hour
swab
taken
day
selfreport
diseas
onset
test
posit
hospitalis
influenza
viru
current
season
inclus
suffer
sari
least
one
system
symptom
fever
malais
headach
myalgia
deterior
gener
condit
deterior
function
statu
least
one
respiratori
symptom
cough
sore
throat
short
breath
patient
elig
includ
studi
institutionalis
unwil
particip
abl
commun
abl
andor
will
give
written
inform
consent
ic
elig
patient
ask
provid
one
throat
one
nose
swab
specimen
influenza
test
multiplex
rtpcr
data
shed
studi
propos
influenza
viru
detect
decreas
day
recruit
limit
patient
swab
day
onset
symptom
swab
done
inform
demograph
clinic
characterist
collect
medic
histori
patient
selfreport
outcom
laboratoryconfirm
influenza
viru
infect
patient
admit
hospit
sari
sari
patient
posit
influenza
nontyp
influenza
b
virus
consid
case
control
group
consist
patient
neg
influenza
viru
infect
exposur
interest
vaccin
trival
season
influenza
vaccin
avail
lithuania
influenza
season
subject
consid
vaccin
vaccin
statu
confirm
gener
practition
gp
record
vaccin
occur
day
diseas
onset
day
select
control
also
sari
onset
otherwis
consid
unvaccin
covari
inform
age
sex
antivir
drug
use
current
hospitalis
transfer
intens
care
unit
hospitalis
due
diseas
exacerb
last
month
length
hospitalis
occurr
underli
medic
condit
cardiovascular
respiratori
renal
rheumatolog
endocrin
diseas
diabet
haematolog
nonhaematolog
cancer
immunodefici
transplant
dementia
stroke
anaemia
accord
intern
classif
diseas
collect
medic
record
onlin
supplementari
appendix
socioeconom
statu
educ
occup
incom
per
household
member
live
urban
rural
area
smoke
statu
bodi
mass
index
bmi
obes
number
hospitalis
number
visit
gp
due
underli
medic
condit
repeat
prescript
preced
year
barthel
score
assess
depend
activ
daili
live
hospitalis
collect
selfreport
nasal
throat
swab
kept
fridg
ward
hour
time
sampl
transport
nation
public
health
laboratori
nphl
sampl
transfer
nphl
within
hour
frozen
transport
nphl
sampl
kept
analys
viral
rna
sampl
isol
use
automat
magnet
particl
method
base
centr
diseas
control
prevent
cdc
recommend
influenza
vaccin
rate
among
risk
group
lithuania
assum
vaccin
rate
among
case
control
respect
achiev
statist
power
confid
level
requir
sampl
size
subject
sampl
size
estim
total
sampl
demograph
clinic
characterist
case
control
compar
use
fisher
chisquar
test
student
ttest
analysi
adjust
confound
variabl
associ
outcom
vaccin
alpha
level
sive
confid
interv
ci
estim
use
formula
studi
conduct
accord
lithuania
legisl
declar
helsinki
kauna
region
biomed
research
ethic
committe
kauna
lithuania
state
data
protect
inspector
approv
date
februari
date
januari
receiv
respect
written
ic
obtain
studi
subject
overal
patient
screen
met
inclus
criteria
subject
gave
ic
includ
studi
ninetyon
subject
neg
influenza
viru
infect
subject
test
posit
influenza
viru
infect
sixtyf
subject
confirm
influenza
viru
infect
includ
case
influenza
subtyp
inconclus
specimen
influenza
type
eight
case
influenza
b
viru
infect
seven
bvictoria
one
unsubtyp
one
coinfect
unsubtyp
influenza
viru
bvictoria
eightyfour
patient
swab
within
day
antivir
administr
administ
antivir
day
swab
patient
swab
day
administr
antivir
addit
influenza
seven
subject
coinfect
two
adenoviru
one
coronaviru
two
metapneumoviru
two
rsv
respiratori
pathogen
isol
studi
particip
rsv
adenoviru
metapneumoviru
rhinoviru
coronaviru
parainfluenza
observ
influenza
peak
studi
occur
week
figur
overlap
nation
detect
influenza
season
peak
lithuania
figur
averag
age
influenza
case
significantli
lower
control
vs
year
old
influenza
case
significantli
less
underli
medic
condit
cardiovascular
lung
diseas
less
often
hospitalis
last
month
due
exacerb
underli
ill
prescrib
oseltamivir
twice
often
tabl
fifteen
subject
vaccin
influenza
season
year
old
tabl
vaccin
occur
day
onset
sari
vaccin
individu
older
like
receiv
season
influenza
vaccin
previou
season
slightli
shorter
length
hospitalis
tabl
influenza
case
appear
cough
less
short
breath
deterior
gener
condit
control
tabl
total
sampl
five
patient
die
hospitalis
within
influenza
confirm
case
includ
one
vaccin
death
within
control
ceas
subject
vaccin
unadjust
sive
point
estim
influenza
influenza
type
influenza
ci
ci
ci
respect
howev
statist
signific
tabl
age
associ
vaccin
statu
outcom
perform
sive
analysi
age
group
year
old
stratifi
age
analysi
sive
point
estim
influenza
influenza
type
subject
year
old
increas
drop
year
old
subject
tabl
case
sive
none
result
stratifi
analysi
statist
signific
due
low
statist
power
analysi
estim
sive
influenza
type
bvictoria
perform
sensit
analysi
scenario
vaccin
influenza
b
case
replac
one
use
howev
unadjust
result
indic
sive
ci
studi
aim
estim
sive
laboratoryconfirm
influenza
viru
infect
patient
admit
hospit
due
sari
lithuania
season
estim
indic
vaccin
effect
influenza
influenza
type
influenza
respect
none
statist
signific
stratifi
age
sive
point
estim
influenza
influenza
type
slightli
increas
year
old
individu
decreas
year
old
due
lack
open
access
precis
subgroup
analysi
result
serv
indicatori
studi
sive
higher
midseason
estim
influenza
report
primari
hospit
patient
popul
denmark
year
old
subject
gp
patient
popul
uk
age
group
lower
point
estim
crude
adjust
predomin
report
multicentr
european
network
hospit
influenza
season
individu
particip
data
metaanalysi
commun
dwell
elderli
confounderadjust
vaccin
effect
estim
result
influenza
season
predomin
influenza
canada
adjust
sive
elderli
found
due
lack
publish
data
report
vaccin
effect
sive
comparison
across
countri
andor
region
still
miss
addit
previou
studi
conduct
group
similar
set
found
higher
sive
season
necessari
point
influenza
influenza
influenza
b
case
predomin
open
access
season
influenza
predomin
season
use
influenza
viru
neg
patient
control
studi
shown
use
differ
control
group
ie
neg
influenza
virus
neg
influenza
virus
posit
respiratori
virus
neg
influenza
respiratori
virus
testneg
design
casecontrol
studi
result
differ
sive
estim
howev
result
far
consist
discuss
studi
design
methodolog
challeng
use
control
group
still
ongo
differ
point
estim
sive
use
differ
control
group
recent
report
confid
interv
estim
overlap
given
inconsist
even
lower
sampl
size
restrict
control
influenza
neg
respiratori
virus
neg
studi
control
group
influenza
viru
neg
patient
remain
valid
choic
seven
influenza
bvictoria
case
detect
studi
although
abl
perform
sive
due
extrem
low
number
influenza
b
case
find
show
circul
strain
mismatch
byamagata
lineag
viru
includ
season
vaccin
confirm
vaccin
influenza
b
case
replac
one
case
well
signific
midseason
estim
found
denmark
five
death
occur
studi
influenza
season
four
subject
posit
influenza
five
subject
least
one
underli
medic
condit
three
four
influenza
case
younger
year
one
influenza
posit
patient
vaccin
influenza
season
hospitalis
patient
develop
unilater
bilater
pneumonia
main
caus
death
among
influenza
case
respiratori
insuffici
due
acut
respiratori
distress
syndrom
high
mortal
studi
sampl
especi
among
influenza
confirm
case
compar
control
reflect
sever
condit
hospitalis
popul
increas
risk
sever
influenzarel
outcom
call
better
influenza
prevent
measur
risk
group
respons
rate
studi
high
exceed
select
bia
reduc
includ
patient
studi
laboratori
result
influenza
statu
known
case
control
similar
regard
demograph
clinic
characterist
outcom
bia
reduc
use
sensit
influenza
detect
method
exposur
statu
verifi
gp
therefor
exposur
misclassif
unlik
togeth
give
us
confid
despit
low
sampl
size
low
precis
sive
estim
bia
testneg
casecontrol
studi
except
unmeasur
confound
abl
assess
limit
studi
sever
limit
first
two
particip
univers
hospit
locat
two
district
countri
howev
infecti
diseas
unit
hospit
main
centr
major
patient
clinic
suspect
influenza
admit
vilniu
kauna
region
cover
lithuanian
popul
low
precis
sive
estim
partli
due
low
number
vaccin
patient
would
requir
much
higher
sampl
size
abl
provid
precis
sive
estim
nevertheless
address
potenti
bias
design
analysi
stage
studi
least
influenza
type
obtain
estim
like
reason
indic
sive
season
lithuania
vaccin
coverag
among
risk
group
low
accord
centr
communic
diseas
aid
elderli
popul
vaccin
influenza
season
sever
european
countri
vaccin
coverag
among
risk
group
vari
portug
northern
ireland
differ
vaccin
rate
european
countri
gener
adopt
recommend
might
explain
differ
commun
activ
differ
vaccin
provis
system
fund
scheme
attitud
trust
season
influenza
vaccin
recommend
england
exampl
gp
provid
encourag
contact
elig
patient
septemb
activ
invit
attend
clinic
get
vaccin
influenza
lithuania
person
invit
usual
sent
vaccin
coverag
among
healthcar
worker
quit
low
like
influenc
patient
decis
well
patient
elig
influenza
vaccin
ie
suffer
underli
condit
year
old
pregnant
women
usual
offer
administ
vaccin
visit
gp
week
vaccin
avail
octoberdecemb
limit
number
patient
would
potenti
will
get
vaccin
activ
invit
addit
routin
sive
assess
inform
influenza
prevent
treatment
strategi
multipl
question
remain
tackl
futur
studi
multipl
year
need
investig
role
previou
influenza
infect
potenti
effect
modifi
vaccin
effect
estim
due
absenc
electron
record
system
inform
laboratoryconfirm
influenza
ill
previou
season
subset
patient
therefor
abl
determin
effect
previou
laboratoryconfirm
influenza
sive
also
bigger
sampl
size
need
monitor
withinseason
wane
immun
determin
whether
time
influenza
immunis
campaign
need
revis
open
access
conclus
although
sive
estim
confid
interv
broad
studi
suggest
moder
effect
influenza
type
even
moder
vaccin
effect
estim
given
high
preval
influenza
hospitalis
case
rel
high
number
death
urgent
need
adopt
effect
vaccin
campaign
strategi
countri
low
vaccin
uptak
rate
ethic
approv
kauna
region
biomed
research
ethic
committe
kauna
lithuania
proven
peer
review
commiss
extern
peer
review
data
share
statement
addit
unpublish
data
avail
share
open
access
open
access
articl
distribut
accord
creativ
common
attribut
non
commerci
cc
bync
licens
permit
other
distribut
remix
adapt
build
upon
work
noncommerci
licens
deriv
work
differ
term
provid
origin
work
properli
cite
use
noncommerci
see
http
creativecommon
org
licens
bync
